Answer
Tafinlar (dabrafenib mesilate), alone or with trametinib, is indicated for adults with unresectable or metastatic melanoma with a BRAF V600 mutation.
Sources for this answer
- Tafinlar 50 mg & 75 mg hard capsulesNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 40Document updated
Sources checked